244 related articles for article (PubMed ID: 35048234)
1. The Optimized Formulation of Tamoxifen-Loaded Niosomes Efficiently Induced Apoptosis and Cell Cycle Arrest in Breast Cancer Cells.
Akbarzadeh I; Farid M; Javidfar M; Zabet N; Shokoohian B; Arki MK; Shpichka A; Noorbazargan H; Aghdaei HA; Hossein-Khannazer N; Timashev P; Makvandi P; Vosough M
AAPS PharmSciTech; 2022 Jan; 23(1):57. PubMed ID: 35048234
[TBL] [Abstract][Full Text] [Related]
2. Fabrication, optimization, and characterization of pH-responsive PEGylated nanoniosomes containing gingerol for enhanced treatment of breast cancer.
Asghari Lalami Z; Tafvizi F; Naseh V; Salehipour M
Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3867-3886. PubMed ID: 37368028
[TBL] [Abstract][Full Text] [Related]
3. In vitro Development of Controlled-Release Nanoniosomes for Improved Delivery and Anticancer Activity of Letrozole for Breast Cancer Treatment.
Ahmadi S; Seraj M; Chiani M; Hosseini S; Bazzazan S; Akbarzadeh I; Saffar S; Mostafavi E
Int J Nanomedicine; 2022; 17():6233-6255. PubMed ID: 36531115
[TBL] [Abstract][Full Text] [Related]
4. Effect of nanovesicular surface-functionalization via chitosan and/or PEGylation on cytotoxicity of tamoxifen in induced-breast cancer model.
Megahed MA; El-Sawy HS; Reda AM; Abd-Allah FI; Abu Elyazid SK; Lila AE; Ismael HR; El-Say KM
Life Sci; 2022 Oct; 307():120908. PubMed ID: 36028168
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis Induction, Cell Cycle Arrest and Anti-Cancer Potential of Tamoxifen-Curcumin Loaded Niosomes Against MCF-7 Cancer Cells.
Fatemizadeh M; Tafvizi F; Shamsi F; Amiri S; Farajzadeh A; Akbarzadeh I
Iran J Pathol; 2022; 17(2):183-190. PubMed ID: 35463725
[TBL] [Abstract][Full Text] [Related]
6. Nanosized paclitaxel-loaded niosomes: formulation, in vitro cytotoxicity, and apoptosis gene expression in breast cancer cell lines.
Pourmoghadasiyan B; Tavakkoli F; Beram FM; Badmasti F; Mirzaie A; Kazempour R; Rahimi S; Larijani SF; Hejabi F; Sedaghatnia K
Mol Biol Rep; 2022 May; 49(5):3597-3608. PubMed ID: 35235156
[TBL] [Abstract][Full Text] [Related]
7. Niosomal delivery of simvastatin to MDA-MB-231 cancer cells.
Akbarzadeh I; Saremi Poor A; Yaghmaei S; Norouzian D; Noorbazargan H; Saffar S; Ahangari Cohan R; Bakhshandeh H
Drug Dev Ind Pharm; 2020 Sep; 46(9):1535-1549. PubMed ID: 32808813
[TBL] [Abstract][Full Text] [Related]
8. Application of Box-Behnken Design in the Preparation, Optimization, and In Vitro Evaluation of Self-Assembly-Based Tamoxifen- and Doxorubicin-Loaded and Dual Drug-Loaded Niosomes for Combinatorial Breast Cancer Treatment.
Kulkarni P; Rawtani D
J Pharm Sci; 2019 Aug; 108(8):2643-2653. PubMed ID: 30905701
[TBL] [Abstract][Full Text] [Related]
9. Co-delivery of doxorubicin and paclitaxel via noisome nanocarriers attenuates cancerous phenotypes in gastric cancer cells.
Rezaei N; Kazem Arki M; Miri-Lavasani Z; Solhi R; Khoramipour M; Rashedi H; Asadzadeh Aghdaei H; Hossein-Khannazer N; Mostafavi E; Vosough M
Eur J Pharm Biopharm; 2023 Jul; 188():33-47. PubMed ID: 37105361
[TBL] [Abstract][Full Text] [Related]
10. Preparation, Optimization and In-Vitro Evaluation of Curcumin-Loaded Niosome@calcium Alginate Nanocarrier as a New Approach for Breast Cancer Treatment.
Akbarzadeh I; Shayan M; Bourbour M; Moghtaderi M; Noorbazargan H; Eshrati Yeganeh F; Saffar S; Tahriri M
Biology (Basel); 2021 Feb; 10(3):. PubMed ID: 33652630
[TBL] [Abstract][Full Text] [Related]
11. Cellular uptake, cytotoxicity and in-vivo evaluation of Tamoxifen citrate loaded niosomes.
Shaker DS; Shaker MA; Hanafy MS
Int J Pharm; 2015 Sep; 493(1-2):285-94. PubMed ID: 26200748
[TBL] [Abstract][Full Text] [Related]
12. Co-encapsulation of hydrophilic and hydrophobic drugs into niosomal nanocarrier for enhanced breast cancer therapy: In silico and in vitro studies.
Amiri S; Pashizeh F; Moeinabadi-Bidgoli K; Eyvazi Y; Akbari T; Salehi Moghaddam Z; Eskandarisani M; Farahmand F; Hafezi Y; Nouri Jevinani H; Seif M; Mousavi-Niri N; Chiani M; Tavakkoli Yaraki M
Environ Res; 2023 Dec; 239(Pt 2):117292. PubMed ID: 37806480
[TBL] [Abstract][Full Text] [Related]
13. Co-Delivery of Ylang Ylang Oil of
Sedky NK; Abdel-Kader NM; Issa MY; Abdelhady MMM; Shamma SN; Bakowsky U; Fahmy SA
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176099
[TBL] [Abstract][Full Text] [Related]
14. Niosomes-loaded selenium nanoparticles as a new approach for enhanced antibacterial, anti-biofilm, and anticancer activities.
Haddadian A; Robattorki FF; Dibah H; Soheili A; Ghanbarzadeh E; Sartipnia N; Hajrasouliha S; Pasban K; Andalibi R; Ch MH; Azari A; Chitgarzadeh A; Kashtali AB; Mastali F; Noorbazargan H; Mirzaie A
Sci Rep; 2022 Dec; 12(1):21938. PubMed ID: 36536030
[TBL] [Abstract][Full Text] [Related]
15. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
[TBL] [Abstract][Full Text] [Related]
16. Optimization, physicochemical characterization, and antimicrobial activity of a novel simvastatin nano-niosomal gel against E. coli and S. aureus.
Akbarzadeh I; Keramati M; Azadi A; Afzali E; Shahbazi R; Chiani M; Norouzian D; Bakhshandeh H
Chem Phys Lipids; 2021 Jan; 234():105019. PubMed ID: 33232724
[TBL] [Abstract][Full Text] [Related]
17. Preparation of Artemisia Turcomanic Encapsulated Niosomal Nanocarriers and Evaluation of Anticancer Activities and Apoptosis Gene Expression Analysis in HeLa Cells.
Eslamian F; Keshtmand Z; Hesampour A
Chem Biodivers; 2023 May; 20(5):e202201160. PubMed ID: 37026601
[TBL] [Abstract][Full Text] [Related]
18. Targeting Colorectal Cancer Cells with Niosomes Systems Loaded with Two Anticancer Drugs Models; Comparative In Vitro and Anticancer Studies.
El-Far SW; Abo El-Enin HA; Abdou EM; Nafea OE; Abdelmonem R
Pharmaceuticals (Basel); 2022 Jun; 15(7):. PubMed ID: 35890115
[TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization, and evaluation of the anticancer activity of artemether-loaded nano-niosomes against breast cancer.
Mirzaei-Parsa MJ; Najafabadi MRH; Haeri A; Zahmatkeshan M; Ebrahimi SA; Pazoki-Toroudi H; Adel M
Breast Cancer; 2020 Mar; 27(2):243-251. PubMed ID: 31621052
[TBL] [Abstract][Full Text] [Related]
20. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
